Outcome for metastatic (M+) medulloblastoma (MB) treated with carboplatin during craniospinal radiotherapy (CSRT) followed by cyclophosphamide (CPM) and vincristine (VCR): Preliminary results of COG 99701 Article

Jakacki, R, Burger, P, Zhou, T et al. (2007). Outcome for metastatic (M+) medulloblastoma (MB) treated with carboplatin during craniospinal radiotherapy (CSRT) followed by cyclophosphamide (CPM) and vincristine (VCR): Preliminary results of COG 99701 . JOURNAL OF CLINICAL ONCOLOGY, 25(18_suppl), 2017-2017. 10.1200/jco.2007.25.18_suppl.2017

cited authors

  • Jakacki, R; Burger, P; Zhou, T; Holmes, E; Packer, R; Goldwein, J; Mehta, M; Pollack, I

authors

publication date

  • June 20, 2007

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6.5 Radiotherapy and other non-invasive therapies
  • Cancer
  • Orphan Drug
  • Radiation Oncology
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 2017

end page

  • 2017

volume

  • 25

issue

  • 18_suppl